Loading insider details...
Beta
Latest Form 4 (May 14, 2026): Tender of Shares of 161,567 APLS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 14, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Tender of Shares | 161,567 | n/a |
| Jan 5, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 7,961 | n/a |
| Oct 16, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Other (see footnotes) | 4,787 | n/a |
| Oct 2, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 31,092 | $702.1K |
| Sep 20, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 31,092 | $713.6K |
| Jan 3, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 6,267 | n/a |
| Sep 24, 2024 | Apellis Pharmaceuticals, Inc. (APLS) | Exercise/Conversion | 4,600 | $60.7K |
| Sep 17, 2024 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 29,476 | $1.06M |
| Jul 1, 2024 | Apellis Pharmaceuticals, Inc. (APLS) | Exercise/Conversion | 900 | $11.9K |
| Jun 21, 2024 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 35,305 | $1.38M |